Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

1.1 List of Tables
1.2 List of Figures

2.1 Breast Cancer Overview

3.1 Breast Cancer - Pipeline Products by Stage of Development
3.2 Breast Cancer - Pipeline Products by Territory
3.3 Breast Cancer - Pipeline Products by Regulatory Path
3.4 Breast Cancer - Pipeline Products by Estimated Approval Date
3.5 Breast Cancer - Ongoing Clinical Trials

4.1 Breast Cancer Companies - Pipeline Products by Stage of Development
4.2 Breast Cancer - Pipeline Products by Stage of Development

7.1 Methodology
7.2 About the Publisher
7.3 Contact

Table 1: Breast Cancer - Pipeline Products by Stage of Development
Table 2: Breast Cancer - Pipeline Products by Territory
Table 3: Breast Cancer - Pipeline Products by Regulatory Path
Table 4: Breast Cancer - Pipeline Products by Estimated Approval Date
Table 5: Breast Cancer - Ongoing Clinical Trials
Table 6: Breast Cancer Companies - Pipeline Products by Stage of Development
Table 7: Breast Cancer - Pipeline Products by Stage of Development
Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Onco 88 - Breast Cancer - Product Status
Table 10: Onco 88 - Breast Cancer - Product Description
Table 11: OncoStain 88 - Breast Cancer - Product Status
Table 12: OncoStain 88 - Breast Cancer - Product Description
Table 13: Abviva Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Mammastatin Serum Assay - Product Status
Table 15: Mammastatin Serum Assay - Product Description
Table 16: Accelerated Medical Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Companion Diagnostic Test - Oxaliplatin - Product Status
Table 18: Companion Diagnostic Test - Oxaliplatin - Product Description
Table 19: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Companion Diagnostic Test - Breast Cancer - Product Status
Table 21: Companion Diagnostic Test - Breast Cancer - Product Description
Table 22: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status
Table 23: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description
Table 24: Diagnostic/Prognostic Assay - Breast Cancer - Product Status
Table 25: Diagnostic/Prognostic Assay - Breast Cancer - Product Description
Table 26: Affichem SA Pipeline Products & Ongoing Clinical Trials Overview
Table 27: AF300 Based Chromatographic Kit - Product Status
Table 28: AF300 Based Chromatographic Kit - Product Description
Table 29: AF300 Based Enzymatic Immunoassay Kit - Product Status
Table 30: AF300 Based Enzymatic Immunoassay Kit - Product Description
Table 31: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Diagnostic Assay - Breast Cancer - Product Status
Table 33: Diagnostic Assay - Breast Cancer - Product Description
Table 34: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 35: mRNA Based Diagnostic Assay - Breast Cancer - Product Status
Table 36: mRNA Based Diagnostic Assay - Breast Cancer - Product Description
Table 37: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: NMP66 Test - Product Status
Table 39: NMP66 Test - Product Description
Table 40: Allarity Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Epirubicin DRP Assay - Product Status

Figure 1: Breast Cancer - Pipeline Products by Stage of Development
Figure 2: Breast Cancer - Pipeline Products by Territory
Figure 3: Breast Cancer - Pipeline Products by Regulatory Path
Figure 4: Breast Cancer - Pipeline Products by Estimated Approval Date
Figure 5: Breast Cancer - Ongoing Clinical Trials